[20031229]RS21583_医疗保险处方药计划:精算价值比较.pdf

上传人:任我行 文档编号:17177 上传时间:2022-06-24 发布时间:2003-12-29 格式:PDF 页数:6 大小:38.13KB
下载 相关 举报
[20031229]RS21583_医疗保险处方药计划:精算价值比较.pdf_第1页
第1页 / 共6页
[20031229]RS21583_医疗保险处方药计划:精算价值比较.pdf_第2页
第2页 / 共6页
[20031229]RS21583_医疗保险处方药计划:精算价值比较.pdf_第3页
第3页 / 共6页
[20031229]RS21583_医疗保险处方药计划:精算价值比较.pdf_第4页
第4页 / 共6页
[20031229]RS21583_医疗保险处方药计划:精算价值比较.pdf_第5页
第5页 / 共6页
点击查看更多>>
资源描述

1、Congressional Research Service The Library of CongressCRS Report for CongressReceived through the CRS WebOrder Code RS21583Updated December 29, 2003Medicare Prescription Drug Plans:Comparison of Actuarial ValuesChris L. PetersonAnalyst in Social LegislationDomestic Social Policy DivisionSummaryOn De

2、cember 8, 2003, the “Medicare Prescription Drug and Modernization Act of2003 was signed into law (H.R. 1, P.L. 108-173). The law adds Part D to Medicare,which establishes a new prescription drug benefit that begins in 2006. This reportcompares the actuarial values of the prescription drug benefit un

3、der the laws standardcoverage and the coverage available to certain low-income beneficiaries. The actuarialvalues of private drug coverage presently available to seniors were also estimated. Theactuarial values of the Part D coverage for low-income beneficiaries were greater thanall of the private p

4、lans that were modeled. The actuarial value of the prescription drugbenefit in the Part D standard coverage was greater than the prescription drug benefit inthe individually purchased Medigap supplemental plans but was less than the typicalprescription drug benefit in employment-based coverage and i

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 法规条令 > CRS 美国国会研究处报告